This article is more than 5 years old. Information may no longer be current.

Carl Zeiss Meditec raises capital for merger

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

JENA, Germany — Carl Zeiss Meditec AG has completed a capital increase for the acquisition of Carl Zeiss Surgical, the company announced.

The company issued 48.8 million new shares to the Prime Standard segment of the German Stock Exchange. Of these, 99.9% were purchased by investors, increasing total share capital to about Euro81.3 million (approximately US$104 million) and allowing the company to complete the merger, according to a press release from Carl Zeiss Meditec.

The acquisition will supplement the company's ophthalmic surgery portfolio and will bring opportunities in the neuro- and ear, nose and throat surgery areas, company officials said in the release.